Skip to main content

Table 3 Clinical Outcomes: Summary of tumor response by RESIST criteria.

From: Stereotactic radiosurgery may contribute to overall survival for patients with recurrent head and neck carcinoma

3A

N-patients

Number of Patients (%)

Complete Response

9 (64.3%)

Partial Response

1 (7.1%)

Stable Disease

1 (7.1%)

Progressed Disease

3 (21.4%)

N+ patients

Complete Response

1 (12.5%)

Progressed Disease

7 (87.5%)

3B

Clinical Stage

Complete Response

Partial Response

Stable Disease

Progressed Disease

rT0N1M0

1

   

rT0N0M1

  

1

 

rT2N0M0

3

   

rT3N0M0

3

1

 

1

rT3N1M0

   

2

rT3N2M0

   

1

rT4N0M0

3

  

2

rT4N1M0

   

2

rT4N2M0

   

2

  1. (A) Tumor response for patients without lymph node metastases (N-) and for patients with lymph node metastases (N+). (B) Tumor response based on clinical stage.
Back to article page

Radiation Oncology

ISSN: 1748-717X

Contact us